Nationwide Fund Advisors’s Fibrocell Science Inc. FCSC Stock Holding History

Nationwide Fund Advisors’s Portfolio FCSC Stock Details FCSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-1,160	Closed	-$44K	–	3332
2016 Q1	$44K	Hold	1,160	–	–	﹤0.01%	3010
2015 Q4	$79K	Hold	1,160	–	–	﹤0.01%	2913
2015 Q3	$67K	Buy	1,160 +119	+11%	+$10.5K	﹤0.01%	2987
2015 Q2	$82K	Buy	+1,041	New	+$70.1K	﹤0.01%	3047
2014 Q2	–	Sell	-1,109	Closed	-$87K	–	3412
2014 Q1	$87K	Hold	1,109	–	–	﹤0.01%	2782
2013 Q4	$68K	Buy	1,109 +224	+25%	+$13K	﹤0.01%	3031
2013 Q3	$58K	Buy	885 +533	+151%	+$43.1K	﹤0.01%	3035
2013 Q2	$32K	Buy	+352	New	+$29.1K	﹤0.01%	3041

Other funds holding FCSC

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nationwide Fund Advisors's FCSC Position: Q2 2016 in Review

Nationwide Fund Advisors sold out of Fibrocell Science Inc. (FCSC) in Q2 2016, closing a stake of 1,160 shares — an estimated $44K sold.

Nationwide Fund Advisors first reported a position in FCSC in Q2 2013 and held it in 8 quarters. The position peaked at $87K in Q1 2014. 44 funds tracked by Wall St. Rank hold FCSC as of Q2 2016.

Nationwide Fund Advisors reported no remaining Fibrocell Science Inc. position as of Q2 2016 after selling out during the quarter.
Nationwide Fund Advisors sold 1,160 Fibrocell Science Inc. shares in Q2 2016, an estimated $44K.
Nationwide Fund Advisors first reported a position in Fibrocell Science Inc. in Q2 2013 and held it in 8 quarters.
Nationwide Fund Advisors's Fibrocell Science Inc. position peaked at $87K in Q1 2014.
44 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q2 2016.

Based on Nationwide Fund Advisors's 13F filing for Q2 2016, filed 9 Aug 2016.